CUE Iron Condor Strategy
CUE (Cue Biopharma, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical enterprise focused on creating biological therapies. Its central objective is the precise manipulation of the human immune system to address a spectrum of severe conditions, such as various cancers, chronic infectious diseases, and autoimmune disorders. The company's leading investigational therapeutic is CUE-101, a specialized fusion protein biologic. This candidate is currently advancing through Phase 1b clinical trials, engineered to specifically identify and activate antigen-specific T cells involved in cancers originating from human papillomavirus. Beyond its flagship program, Cue Biopharma is also developing a range of other innovative platforms: CUE-102, another fusion protein biologic designed to stimulate specific T cells to combat cancer; CUE-103, an Immuno-STAT from the CUE-100 series, which is developed to target the KRAS G12V mutation relevant in diseases like colorectal, lung, and pancreatic cancers; CUE-200, which concentrates on cell surface receptors such as CD80 and/or 4-1BBL to counteract T cell exhaustion often seen in chronic infections; and the CUE-300 and CUE-400 frameworks, conceptual platforms aimed at treating diverse autoimmune conditions. Cue Biopharma maintains key strategic alliances, including collaborations with Merck Sharp & Dohme Corp. for the research and development of its unique biologics targeting autoimmune indications, with LG Chem Life Sciences for advancing Immuno-STATs in the field of oncology, and with the Albert Einstein College of Medicine.
CUE (Cue Biopharma, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $82.5M, a beta of 2.46 versus the broader market, a 52-week range of 4.97-45.5, average daily share volume of 208K, a public-listing history dating back to 2018, approximately 29 full-time employees. These structural characteristics shape how CUE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.46 indicates CUE has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a iron condor on CUE?
An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes.
CUE snapshot
As of September 29, 2026, spot at $28.46, ATM IV 43.80%, IV rank 8.59%, expected move 12.56%. The iron condor on CUE below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this iron condor structure on CUE specifically: CUE IV at 43.80% is on the cheap side of its 1-year range, which means a premium-selling CUE iron condor collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 12.56% (roughly $3.57 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CUE expiries trade a higher absolute premium for lower per-day decay. Position sizing on CUE should anchor to the underlying notional of $28.46 per share and to the trader's directional view on CUE stock.
CUE iron condor setup
The CUE iron condor below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CUE at $28.46 on that close, the first option leg uses a $29.88 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CUE chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CUE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Call | $29.88 | N/A |
| Buy 1 | Call | $31.31 | N/A |
| Sell 1 | Put | $27.04 | N/A |
| Buy 1 | Put | $25.61 | N/A |
CUE iron condor risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit.
CUE iron condor payoff curve
Modeled P&L at expiration across a range of underlying prices for the iron condor on CUE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use iron condor on CUE
Iron condors on CUE are a delta-neutral premium-collection structure that profits if CUE stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
CUE thesis for this iron condor
The market-implied 1-standard-deviation range for CUE extends from approximately $24.89 on the downside to $32.03 on the upside. A CUE iron condor is a delta-neutral premium-collection structure that pays off when CUE stays inside the inner short strikes through expiration; the wing width should reflect the trader's tolerance for the maximum loss scenario where the underlying breaches an outer strike. Current CUE IV rank near 8.59% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CUE at 43.80%. As a Healthcare name, CUE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CUE-specific events.
CUE iron condor positions are structurally neutral / range-bound; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CUE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CUE alongside the broader basket even when CUE-specific fundamentals are unchanged. Short-premium structures like a iron condor on CUE carry tail risk when realized volatility exceeds the implied move; review historical CUE earnings reactions and macro stress periods before sizing. Always rebuild the position from current CUE chain quotes before placing a trade.
Frequently asked questions
- What is a iron condor on CUE?
- A iron condor on CUE is the iron condor strategy applied to CUE (stock). The strategy is structurally neutral / range-bound: An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes. With CUE stock at $28.46 on the most recent close, the strikes shown on this page are snapped to the nearest listed CUE chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are CUE iron condor max profit and max loss calculated?
- Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit. For the CUE iron condor priced from the end-of-day chain at a 30-day expiry (ATM IV 43.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CUE iron condor?
- The breakeven for the CUE iron condor priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CUE market-implied 1-standard-deviation expected move in the same options snapshot is approximately 12.56%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a iron condor on CUE?
- Iron condors on CUE are a delta-neutral premium-collection structure that profits if CUE stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
- How does current CUE implied volatility affect this iron condor?
- CUE ATM IV is at 43.80% with IV rank near 8.59%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.